| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 316 |
| 1 | CARBOPLATIN | 259 |
| 2 | ETOPOSIDE | 193 |
| 3 | AMIKACIN | 183 |
| 4 | GENTAMICIN SULFATE | 139 |
| 5 | CYCLOPHOSPHAMIDE | 124 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 124 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 124 |
| 8 | LINEZOLID | 123 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 119 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GENTIAN VIOLET | 2 | 0.0385 |
| 1 | EFLORNITHINE HYDROCHLORIDE | 1 | 0.0238 |
| 2 | CEFOXITIN SODIUM | 33 | 0.0237 |
| 3 | DACTINOMYCIN | 36 | 0.0163 |
| 4 | AMIKACIN SULFATE | 25 | 0.0144 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 119 | 0.0142 |
| 6 | INTERLEUKIN-10 | 5 | 0.0139 |
| 7 | CLOFAZIMINE | 74 | 0.0114 |
| 8 | CYCLOSERINE | 26 | 0.0112 |
| 9 | IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS | 1 | 0.0109 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 529 |
| 1 | Aminoglycoside Antibacterial [EPC] | 279 |
| 2 | Topoisomerase Inhibitor [EPC] | 196 |
| 3 | Alkylating Drug [EPC] | 179 |
| 4 | Corticosteroid [EPC] | 144 |
| 5 | Oxazolidinone Antibacterial [EPC] | 123 |
| 6 | Glycopeptide Antibacterial [EPC] | 119 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 115 |
| 8 | Macrolide Antimicrobial [EPC] | 115 |
| 9 | Antimycobacterial [EPC] | 100 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 36 | 0.0163 |
| 1 | Rifamycin Antimycobacterial [EPC] | 24 | 0.0069 |
| 2 | Aminoglycoside Antibacterial [EPC] | 279 | 0.0063 |
| 3 | Tetracycline-class Antibacterial [EPC] | 46 | 0.0058 |
| 4 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 6 | 0.0055 |
| 5 | Antimycobacterial [EPC] | 100 | 0.0041 |
| 6 | Oxazolidinone Antibacterial [EPC] | 123 | 0.0041 |
| 7 | Topoisomerase Inhibitor [EPC] | 196 | 0.0025 |
| 8 | Macrolide Antimicrobial [EPC] | 115 | 0.0022 |
| 9 | Platinum-based Drug [EPC] | 529 | 0.0019 |